Performance of CNMD CONMED | -43.1% in 12m
Compare CNMD with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare CONMED with its related Sector/Index XLV
Performance Duell CNMD vs XLV
TimeFrame | CNMD | XLV |
---|---|---|
1 Day | -1.41% | 0.40% |
1 Week | 5.25% | 0.69% |
1 Month | -9.18% | -1.27% |
3 Months | -15.0% | -1.44% |
6 Months | -30.7% | 11.14% |
12 Months | -43.1% | 7.58% |
YTD | -35.6% | 2.26% |
Rel. Perf. 1m | -0.84 | |
Rel. Perf. 3m | -4.96 | |
Rel. Perf. 6m | -4.58 | |
Rel. Perf. 12m | -6.37 |
Is CONMED a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, CONMED is currently (May 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 9.04 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNMD as of May 2024 is 60.17. This means that CNMD is currently overvalued and has a potential downside of -14.95% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNMD as of May 2024 is 60.17. This means that CNMD is currently overvalued and has a potential downside of -14.95% (Sold with Premium).
Is CNMD a buy, sell or hold?
- Strong Buy: 1
- Buy: 4
- Hold: 3
- Sell: 0
- Strong Sell: 0
Values above 0%: CNMD is performing better - Values below 0%: CNMD is underperforming
Compare CNMD with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 3.97% | -8.82% | -50.12% | -70.14% |
US NASDAQ 100 | QQQ | 3.52% | -9.13% | -50.41% | -80.40% |
US Dow Jones Industrial 30 | DIA | 4.04% | -9.13% | -45.68% | -60.73% |
German DAX 40 | DBXD | 4.99% | -9.17% | -50.52% | -56.57% |
UK FTSE 100 | ISFU | 4.44% | -12.78% | -44.66% | -51.89% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.05% | -12.58% | -32.59% | -31.97% |
Hongkong Hang Seng | HSI | 0.57% | -18.01% | -29.75% | -29.03% |
Japan Nikkei 225 | EXX7 | 2.63% | -7.05% | -46.46% | -62.83% |
India NIFTY 50 | INDA | 5.55% | -9.85% | -49.22% | -69.88% |
Brasil Bovespa | EWZ | 3.42% | -10.81% | -35.26% | -62.42% |
CNMD CONMED vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.57% | -7.70% | -51.99% | -83.82% |
Consumer Discretionary | XLY | 5.36% | -9.72% | -43.24% | -66.25% |
Consumer Staples | XLP | 5.13% | -11.32% | -42.62% | -44.38% |
Energy | XLE | 8.46% | -4.31% | -41.51% | -63.45% |
Financial | XLF | 4.49% | -7.98% | -53.71% | -72.44% |
Health Care | XLV | 4.56% | -7.91% | -41.85% | -50.72% |
Industrial | XLI | 4.82% | -7.86% | -54.14% | -69.85% |
Materials | XLB | 5.47% | -6.27% | -46.81% | -58.53% |
Real Estate | XLRE | 4.82% | -5.66% | -39.51% | -45.57% |
Technology | XLK | 3.14% | -8.44% | -49.70% | -79.74% |
Utilities | XLU | 2.76% | -14.70% | -44.13% | -46.18% |
Aerospace & Defense | XAR | 2.05% | -11.92% | -49.09% | -69.22% |
Biotech | XBI | -0.67% | -9.62% | -60.35% | -49.25% |
Homebuilder | XHB | 2.97% | -7.59% | -71.01% | -95.40% |
Retail | XRT | 3.77% | -8.66% | -52.19% | -66.33% |
Does CONMED outperform its market, is CNMD a Sector Leader?
No, over the last 12 months CONMED (CNMD) made -43.14%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.58%.
Over the last 3 months CNMD made -14.97%, while XLV made -1.44%.
No, over the last 12 months CONMED (CNMD) made -43.14%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.58%.
Over the last 3 months CNMD made -14.97%, while XLV made -1.44%.
Period | CNMD | XLV | S&P 500 |
---|---|---|---|
1 Month | -9.18% | -1.27% | -0.36% |
3 Months | -14.97% | -1.44% | 4.90% |
12 Months | -43.14% | 7.58% | 27.00% |